Haribo recalls candy after cannabis found in gummies, family gets sick
The Brief
A family in the Netherlands became unwell after eating a popular Haribo candy.
Food safety investigators found some bags were tainted with cannabis.
They're still trying to figure out how the cannabis got into the candy.
Haribo has recalled bags of candy in the Netherlands after a family reported getting sick and sampling found cannabis in the gummies.
What we know
The Netherlands Food and Consumer Product Safety Authority told the Netherlands outlet Hart van Nederland that several members of a family felt unwell after eating Haribo Happy Cola F!ZZ gummies. A sampling of the candy revealed cannabis in three bags, leading Haribo to recall the candy.
The recall includes 1kg packs of Haribo Happy Cola F!ZZ with a best-before date of January 2026. The recall only impacts the Netherlands. No products in the U.S. are affected.
RELATED: Ice cream recall issued due to potential plastic contamination
What we don't know
It's still unclear how the cannabis got into the candy, or how many people reported feeling unwell. It's also not clear whether the bags were actually made by Haribo, or if they were fake.
RELATED: Heavy cannabis use linked to impaired working memory, new study finds
What they're saying
A spokesperson for Germany-based Haribo told BBC the company is working with police to "establish the facts around the contamination."
The Netherlands food safety agency warned that eating the recalled candy "can lead to health complaints, such as dizziness."
"Do not eat the sweets," the agency said.
The Source
This report includes information from BBC and the Netherlands news outlet Hart van Nederland.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Exploring Undiscovered Gems in Europe May 2025
As European markets navigate the challenges posed by new U.S. tariff threats and a contraction in business activity, investors are keenly observing how these dynamics impact small-cap stocks across the region. In this environment, identifying promising companies involves looking for those that demonstrate resilience through strong fundamentals and the ability to adapt to shifting economic landscapes. Name Debt To Equity Revenue Growth Earnings Growth Health Rating AB Traction NA 5.39% 5.24% ★★★★★★ Linc NA 101.28% 29.81% ★★★★★★ Intellego Technologies 11.59% 68.05% 72.76% ★★★★★★ Caisse Regionale de Credit Agricole Mutuel Toulouse 31 19.46% 0.47% 7.14% ★★★★★☆ Decora 18.47% 11.59% 10.86% ★★★★★☆ Dekpol 63.20% 11.99% 14.08% ★★★★★☆ Viohalco 91.31% 12.25% 17.37% ★★★★☆☆ Evergent Investments 5.39% 8.97% 21.29% ★★★★☆☆ Castellana Properties Socimi 53.49% 6.64% 21.96% ★★★★☆☆ Eurofins-Cerep 0.46% 6.80% 6.93% ★★★★☆☆ Click here to see the full list of 328 stocks from our European Undiscovered Gems With Strong Fundamentals screener. We'll examine a selection from our screener results. Simply Wall St Value Rating: ★★★★☆☆ Overview: Castellana Properties Socimi, S.A. is a real estate investment company focused on acquiring and managing retail and office properties, with a market capitalization of €912.57 million as of December 20, 2016. Operations: Castellana Properties generates revenue primarily from its retail and office segments, with retail contributing €64.73 million and offices €22.88 million. Castellana Properties, a nimble player in the European real estate market, has shown robust financial health with debt to equity ratio dropping from 87.6% to 53.5% over five years and net debt to equity at a satisfactory 35.2%. Despite earnings growth of 7.7% trailing industry peers at 14.9%, Castellana remains free cash flow positive and boasts high-quality earnings with interest payments well-covered by EBIT at 6.5 times coverage. The recent acquisition of Bonaire Shopping Centre for €305 million enhances its portfolio, promising an attractive cash-on-cash yield around 8.5%, supported by strategic funding and seller-provided NOI guarantees worth €32.85 million over eighteen months post-acquisition. Unlock comprehensive insights into our analysis of Castellana Properties Socimi stock in this health report. Gain insights into Castellana Properties Socimi's past trends and performance with our Past report. Simply Wall St Value Rating: ★★★★★★ Overview: Incap Oyj, along with its subsidiaries, offers electronics manufacturing services across Europe, North America, and Asia with a market capitalization of €318.51 million. Operations: Incap Oyj generates revenue primarily from its electronics manufacturing services, amounting to €232.02 million. The company's financial performance can be analyzed through its net profit margin, which provides insight into profitability relative to total revenue. Incap Oyj, a small-cap player in the electronics manufacturing sector, is making strategic moves to bolster its global footprint. Recent investments in advanced surface-mount technology (SMT) lines across its UK and US facilities have significantly boosted production capacity by over 55% and 110% respectively. The company's net income for Q1 2025 was €3.78 million, down from €4.95 million the previous year, yet it continues to trade at a compelling value with shares priced at €9.66 against a target of €12.73. Despite geopolitical challenges, Incap's ongoing upgrades position it well for future growth opportunities. Incap Oyj's strategic investments in India may enhance production efficiency and revenue margins; click here to explore the full narrative on the company's growth potential. Simply Wall St Value Rating: ★★★★★☆ Overview: Raisio plc is a company that, along with its subsidiaries, focuses on the production and sale of food and food ingredients across Finland, the United Kingdom, Ireland, Belgium, and the Netherlands; it has a market capitalization of approximately €404.83 million. Operations: Raisio's revenue streams are primarily derived from its Healthy Food segment (€155.80 million) and Healthy Ingredients segment (€110.80 million). The company experiences a net profit margin trend that warrants attention, as it reflects the efficiency of its operations in converting revenues into actual profit. Raisio, a nimble player in the food sector, seems to be on solid financial footing with cash exceeding its total debt. The company reported a net income of €5.1 million for Q1 2025, up from €3.5 million the previous year, and earnings per share rose to €0.03 from €0.02. Despite this progress, Raisio's 5-year debt-to-equity ratio climbed slightly to 0.9%, indicating some leverage increase over time. Trading at about 21% below estimated fair value suggests potential upside for investors keeping an eye on valuation metrics while benefiting from high-quality past earnings and positive free cash flow trends. Take a closer look at Raisio's potential here in our health report. Learn about Raisio's historical performance. Dive into all 328 of the European Undiscovered Gems With Strong Fundamentals we have identified here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BME:YCPS HLSE:ICP1V and HLSE:RAIVV. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
German Bunds Expected to Be Supported by Data, Likely ECB Rate Cut
The 10-year Bund yield was largely flat and bullish momentum in Bunds looked set to continue this week, supported by a likely ECB rate cut and eurozone inflation reaching the 2% target.
Medscape
an hour ago
- Medscape
Remission, Attaining CV Risk Targets Drops CVD Risk in Lupus
Patients with systemic lupus erythematosus (SLE) had more than double the risk for atherosclerosis progression over 10 years than healthy control individuals, but maintaining cardiovascular risk factor (CVRF) targets and achieving sustained disease remission significantly reduced this risk. METHODOLOGY: Researchers collected carotid ultrasound measurements from 111 patients with SLE and 94 age- and sex-matched controls, including baseline measurements from 2012 to 2013 with follow-up assessments at 3, 7, and 10 years. They tracked carotid plaque progression, CVRF target attainment on the basis of the 2016 European Society of Cardiology Guidelines on cardiovascular disease (CVD) prevention and additional CVD risk modifiers, and incident CVD events over 10 years and looked for predictors of plaque progression. TAKEAWAY: Patients with SLE demonstrated a 2.3-fold higher risk for carotid plaque progression than healthy control individuals (incidence rate ratio [IRR], 2.26; 95% CI, 1.34-3.81; P = .002). = .002). Each CVRF maintained at target during the 10-year follow-up reduced plaque progression risk by 32% (IRR, 0.68; 95% CI, 0.53-0.89; P = .004). = .004). Achievement of definition of remission in SLE for ≥ 75% of follow-up decreased risk for plaque progression by 43% (IRR, 0.57; 95% CI, 0.34-0.95; P = .033). = .033). Persistent triple antiphospholipid antibody positivity increased 10-year risk for incident cardiovascular events in SLE more than sevenfold (hazard ratio, 7.52; P = .014). IN PRACTICE: 'Patients with SLE experience a 2.3-fold higher 10-year atherosclerosis progression risk than [healthy controls], which is significantly mitigated by sustained [cardiovascular risk factor] control and prolonged clinical remission,' the study authors wrote in the abstract. 'Carotid ultrasound may have an additive role in enhancing CVD risk assessment in patients with SLE.' SOURCE: Maria G. Tektonidou, MD, PhD, of the National and Kapodistrian University of Athens, Athens, Greece, presented the study at the 16th International Congress on Systemic Lupus Erythematosus in Toronto. LIMITATIONS: The study sample was relatively small. Carotid ultrasound is dependent on operator skill and experience, which can lead to interobserver and intraobserver variability. DISCLOSURES: Funding information for this research was not provided. Disclosure information for the authors was not available.
